Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
22.25
+1.01 (4.76%)
At close: Nov 21, 2025, 4:00 PM EST
22.11
-0.14 (-0.63%)
After-hours: Nov 21, 2025, 7:52 PM EST
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $1.14B in the quarter ending September 30, 2025, with 10.39% growth. This brings the company's revenue in the last twelve months to $4.59B, up 3.08% year-over-year. In the year 2024, Elanco Animal Health had annual revenue of $4.44B with 0.50% growth.
Revenue (ttm)
$4.59B
Revenue Growth
+3.08%
P/S Ratio
2.40
Revenue / Employee
$485,820
Employees
9,450
Market Cap
11.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
| Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
| Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
| Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
| Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ELAN News
- 2 days ago - Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats - Reuters
- 2 days ago - Elanco's Credelio™ CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats - PRNewsWire
- 2 days ago - Elanco Animal Health Stock Is Undervalued: Analyst - Benzinga
- 3 days ago - Elanco to Participate in the Upcoming Investor Conferences - PRNewsWire
- 5 days ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 10 days ago - Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health - PRNewsWire
- 18 days ago - Elanco Animal Health Incorporated (ELAN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Elanco Animal Health Reports Third Quarter 2025 Results - PRNewsWire